IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

SR One Capital Management, LP

Q1 2022 Holdings

Filed 2022-05-10 | 3 holdings | $195.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Design Therapeutics Inc(DSGN)COM25056L103$90.9K5,626,47646.5%
Arcellx Inc.(ACLX)COMMON STOCK03940C100$77.1K5,500,00739.5%
Effector Therapeutics IncCOM28202V108$27.4K6,822,11414.0%